SKAN Group AG (FRA:7VG) Stock Based Compensation: €0.0 Mil (TTM As of Dec. 2025)


FRA:7VG SKAN Group AG FRA:7VG
62 GF Score
Price €59.00
GF Value €90.91
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is SKAN Group AG Stock Based Compensation?

SKAN Group AG FRA:7VG +2.61% 62 Stock Based Compensation is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:7VG with a GF Score™ of 62/100 and a GF Value™ of €90.91 (Significantly Undervalued). The stock has 6 warning signs investors should review.

SKAN Group AG's Stock Based Compensation for the six months ended in Dec. 2025 was €0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

SKAN Group AG Stock Based Compensation Related Terms

SKAN Group AG Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for SKAN Group AG's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SKAN Group AG Stock Based Compensation Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:7VG
62GF Score
SKAN Group AG FRA:7VG
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SKAN Group AG Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

What does a Stock Based Compensation of €0.0 Mil mean?
SKAN Group AG (FRA:7VG) has a Stock Based Compensation of €0.0 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for SKAN Group AG and its competitors.
Is SKAN Group AG's Stock Based Compensation too high?
SKAN Group AG's current Stock Based Compensation is €0.0 Mil. Overall, SKAN Group AG has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Stock Based Compensation compare to ISRG and BDX?
SKAN Group AG's Stock Based Compensation of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for SKAN Group AG and its competitors. SKAN Group AG's current Stock Based Compensation is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.91, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current Stock Based Compensation is €0.0 Mil. SKAN Group AG's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current Stock Based Compensation is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SKAN Group AG (FRA:7VG) Overvalued in 2026?

Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued. The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.91. GuruFocus considers SKAN Group AG to be Significantly Undervalued.

Key valuation signals for FRA:7VG:

  • Stock Based Compensation: €0.0 Mil
  • GF Value™: €90.91 vs. price of €59.00 (35.1% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SKAN Group AG Business Description

Address Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
62GF Score

Get the complete analysis for FRA:7VG

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€59.00
Price
€90.91
GF Value